Eun Jung Son
Overview
Explore the profile of Eun Jung Son including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
30
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kang S, Kim G, Kim B, Son E, Do J, Lee J
J Cachexia Sarcopenia Muscle
. 2024 Jun;
15(4):1568-1577.
PMID: 38894551
Background: Pre-haemodialysis (HD) serum creatinine levels are reliable and inexpensive markers of muscle mass and important predictors of survival in patients with stable chronic HD. We aimed to assess whether...
2.
Jeon J, Kim G, Kim B, Son E, Do J, Lee J, et al.
Clin Kidney J
. 2024 May;
17(5):sfae116.
PMID: 38766271
Background: The guidelines recommended target and minimum single-pool / are 1.4 and 1.2, respectively, in hemodialysis patients. However, the optimal hemodialysis dose remains controversial. We investigated the effects of /...
3.
Lho Y, Kim G, Kim B, Son E, Kang S
Pharmaceuticals (Basel)
. 2024 Apr;
17(4).
PMID: 38675457
(1) Background: Few studies have investigated the association between the intensity of statins and patient survival rates in patients undergoing hemodialysis (HD) as primary outcomes. This study aimed to evaluate...
4.
Kang S, Kim G, Kim B, Son E, Do J
J Clin Med
. 2024 Apr;
13(8).
PMID: 38673676
: We evaluated the impact of warfarin use on the clinical outcomes of patients with atrial fibrillation who were undergoing hemodialysis (HD). : A retrospective analysis was conducted utilizing data...
5.
Kang S, Kim B, Son E, Kim G, Do J
PLoS One
. 2024 Mar;
19(3):e0301458.
PMID: 38551953
Background: Previous studies have reported inconsistent results regarding the advantages or disadvantages of spironolactone use in patients undergoing hemodialysis (HD). This study aimed to evaluate survival according to the use...
6.
Kang S, Kim G, Kim B, Son E, Do J
Ren Fail
. 2024 Mar;
46(1):2313173.
PMID: 38522955
Background: This study aimed to evaluate the patient survival rates based on the use of angiotensin-converting enzyme inhibitor (ACEI) or angiotensin II receptor blocker (ARB) in a large cohort of...
7.
Kang S, Kim B, Son E, Kim G, Do J
Semin Dial
. 2023 Dec;
37(3):220-227.
PMID: 38140722
Introduction: Results on the association between the use of renin-angiotensin system blockades (RASBs) and vascular access-related outcomes are inconsistent. We aimed to compare vascular access-related outcomes according to the use...
8.
Kang S, Kim G, Kim B, Son E, Do J
J Clin Med
. 2023 Jul;
12(14).
PMID: 37510864
Data to draw definite conclusions regarding the association between proton pump inhibitor (PPI) and all-cause mortality in patients undergoing hemodialysis (HD) remain insufficient. The object of this retrospective study was...
9.
Kang S, Kim B, Son E, Kim G, Do J
Am J Nephrol
. 2023 May;
54(3-4):117-125.
PMID: 37231773
Introduction: There were insufficient pieces of evidence regarding the effect of the two drugs (allopurinol and febuxostat) on patient survival in hemodialysis (HD) patients. Herein, we aimed to compare the...
10.
Kang S, Kim B, Son E, Kim G, Do J
J Clin Med
. 2023 May;
12(9).
PMID: 37176742
Additional studies are needed to confirm whether the use of renin-angiotensin system blockers (RASBs) induces survival benefits in patients on hemodialysis (HD). This study aimed to evaluate patient survival with...